Concepedia

Manjulika Shukla

MS

25

Publications

670

Citations

16

H-Index

2018

Active since

Affiliations

Central Drug Research Institute(Current)

Academy of Scientific and Innovative Research

National Institute of Pharmaceutical Education and Research

Indian Institute of Chemical Technology

Birla Institute of Technology and Science - Hyderabad Campus

Manjulika Shukla is an author at Central Drug Research Institute specializing in pharmacology, medicine, and drug resistance.

ORCID

Top concepts

Publications per year

2018–2023

25

Publications

25

Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus

Srikanth Gatadi, Jitendra Gour, Manjulika Shukla et al. · European Journal of Medicinal Chemistry · 2018 · 67 citations

, , +8

Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis

Satyaveni Malasala, Mohammad Naiyaz Ahmad, Ravikumar Akunuri et al. · European Journal of Medicinal Chemistry · 2020 · 63 citations

, , +13

Repurposing disulfiram for treatment of Staphylococcus aureus infections

Ritesh Thakare, Manjulika Shukla, Grace Kaul et al. · International Journal of Antimicrobial Agents · 2019 · 49 citations

, , +5

Rationally designed curcumin based ruthenium(<scp>ii</scp>) antimicrobials effective against drug-resistant <i>Staphylococcus aureus</i>

Payal Srivastava, Manjulika Shukla, Grace Kaul et al. · Dalton Transactions · 2019 · 46 citations

, , +17

Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis

Uttam B. Karale, Vagolu Siva Krishna, Eruva Vamshi Krishna et al. · European Journal of Medicinal Chemistry · 2019 · 43 citations

, , +10

Rows per page

1–5 of 25